Age-related chronic inflammation accompanied with cancer, smoking, subclinical disorder (atherosclerosis, sarcopenia and cognitive decline) and obesity seem to contribute to systemic increase of IL-6/sIL-6R in an elderly population15, 17. This evidence concerns the gene IL6 and cancer.